SpringWorks Therapeutics Inc
SpringWorks Therapeutics Inc logo
SWTX

SpringWorks Therapeutics Inc (SWTX)

$25.096%

Market is closed
– opens on 8 PM, 05 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$23.03
Day's Range
$25.14
$13.6
52-Week Range
$74.97
1 month return4.98%
3 month return3.54%
1 year return59.98%
5 year return10.87%

Company Information

SpringWorks is a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. SpringWorks has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers. SpringWorks' strategic approach and operational excellence in clinical development have enabled it to rapidly advance its two lead product candidates into late-stage clinical trials while simultaneously entering into multiple shared-value partnerships with industry leaders to expand its portfolio.
OrganizationSpringWorks Therapeutics Inc
Employees222
CEOMr. Saqib Islam J.D.
IndustryHealth Technology

Analyst Recommendation

based on 6 analysts ratings

Buy
100%
Buy
0%
Hold
0%
Sell

Based on 6 Wall street analysts offering stock ratings for SpringWorks Therapeutics Inc(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 172.62%

Current

$25.09

Target

$68.4

Recommendation Trend

Based on 6 analyst

Current1M Ago3M Ago
Buy
6
11
11
Hold
0
1
1
Sell
0
0
0
Consensus
BUY
BUY
BUY

Highlights

Market Capitalization
1.5B
Book Value
$9.86
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-4.23
Wall Street Target Price
68.4

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)
2.43
Enterprise Value
840.4M
Enterprise Value/Revenue
64.18
Enterprise Value/Ebitda
-3.27

Technicals

Beta
0.63
50 Day MA
25.28
200 Day MA
35.03

Institutional Holdings

FMR Inc

11.88%

Orbimed Advisors, LLC

9.66%

Bain Capital Life Sciences Investors, LLC

7.74%

Perceptive Advisors LLC

6.2%

EcoR1 Capital, LLC

5.55%

Boxer Capital LLC

5.48%

Discover more

Frequently Asked Questions

What is SpringWorks Therapeutics Inc share price today?

Can Indians buy SpringWorks Therapeutics Inc shares?

How can I buy SpringWorks Therapeutics Inc shares from India?

Can Fractional shares of SpringWorks Therapeutics Inc be purchased?

What are the documents required to start investing in SpringWorks Therapeutics Inc stocks?

What are today’s High and Low prices of SpringWorks Therapeutics Inc?

What are today’s traded volumes of SpringWorks Therapeutics Inc?

What is today’s market capitalisation of SpringWorks Therapeutics Inc?

What is the 52 Week High and Low Range of SpringWorks Therapeutics Inc?

How much percentage SpringWorks Therapeutics Inc is down from its 52 Week High?

How much percentage SpringWorks Therapeutics Inc is up from its 52 Week low?

What are the historical returns of SpringWorks Therapeutics Inc?

Who is the Chief Executive Officer (CEO) of SpringWorks Therapeutics Inc?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*